8th Annual Clinical Cancer Genetics and Genomics Conference 2019

Topics

• Benefits and limitations of applying NGS information into cancer genetic/genomic risk assessment
• Clinical utility of polygenic risk scores in cancer risk assessment
• Evidence-based cancer screening and prevention recommendations to clinical cases with pathogenic variants in moderate risk genes
• Challenges related to broad genomic analyses, such as panels, exomes and paired tumor/germline genetic testing that yield incidental findings
• The importance of clinical-research collaborations to characterize lesser-known cancer risk genes
• The significance of germline findings in somatic tumor testing